• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Monoclonal Antibodies for COVID-19.

作者信息

Lloyd Elizabeth C, Gandhi Tejal N, Petty Lindsay A

机构信息

University of Michigan Health System, Ann Arbor.

出版信息

JAMA. 2021 Mar 9;325(10):1015. doi: 10.1001/jama.2021.1225.

DOI:10.1001/jama.2021.1225
PMID:33544136
Abstract
摘要

相似文献

1
Monoclonal Antibodies for COVID-19.用于治疗新冠病毒病的单克隆抗体
JAMA. 2021 Mar 9;325(10):1015. doi: 10.1001/jama.2021.1225.
2
COVID-19 Updates: Monoclonal Antibodies for COVID-19.新冠疫情最新消息：用于治疗新冠的单克隆抗体
Med Lett Drugs Ther. 2022 Jan 24;64(1642):16.
3
Audio Interview: Capitalizing on Immune Responses to Covid-19.音频访谈：利用对新冠病毒的免疫反应
N Engl J Med. 2020 May 21;382(21):e93. doi: 10.1056/NEJMe2019020.
4
Monoclonal Antibodies: Medical Uses for the Prevention and Treatment of Disease.单克隆抗体：疾病预防与治疗的医学用途。
Am J Respir Crit Care Med. 2021 Jun 1;203(11):P26-P27. doi: 10.1164/rccm.2021C3.
5
Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis Can't Come Fast Enough for Some People.对于一些人来说，用于新冠病毒暴露前预防的单克隆抗体来得不够快。
JAMA. 2021 Nov 16;326(19):1895-1897. doi: 10.1001/jama.2021.19534.
6
An EUA for Bamlanivimab-A Monoclonal Antibody for COVID-19.用于治疗新冠肺炎的巴尼韦单抗-A单克隆抗体紧急使用授权。
JAMA. 2021 Mar 2;325(9):880-881. doi: 10.1001/jama.2020.24415.
7
Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19.成功使用 casirivimab/imdevimab 抗刺突单克隆抗体增强了一名接受抗 CD20 治疗的难治性 COVID-19 女性的中和抗体。
J Infect Chemother. 2022 Jul;28(7):991-994. doi: 10.1016/j.jiac.2022.03.002. Epub 2022 Mar 23.
8
Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report.孕期有症状的新冠病毒病的单克隆抗体治疗：初步报告
Am J Obstet Gynecol. 2021 Dec;225(6):688-689. doi: 10.1016/j.ajog.2021.08.025. Epub 2021 Aug 25.
9
The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access.单克隆抗体面临的未来挑战：从获批到可及性
JAMA. 2020 Dec 1;324(21):2151-2152. doi: 10.1001/jama.2020.21872.
10
Audio Interview: Monoclonal Antibodies and Booster Shots.音频访谈：单克隆抗体与加强针
N Engl J Med. 2021 Aug 12;385(7):e29. doi: 10.1056/NEJMe2113398.

引用本文的文献

1
mRNA-based platform for preventing and treating by targeted staphylococcal enterotoxin B.基于信使核糖核酸的靶向葡萄球菌肠毒素B预防和治疗平台。
Front Immunol. 2024 Nov 21;15:1490044. doi: 10.3389/fimmu.2024.1490044. eCollection 2024.
2
Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study.替沙格韦单抗-西加韦单抗预防透析患者新冠病毒突破性感染的前瞻性研究
Clin Kidney J. 2024 Oct 18;17(11):sfae309. doi: 10.1093/ckj/sfae309. eCollection 2024 Nov.
3
Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information.
面对不确定性制定药物审批决策：累积证据与信息价值。
Med Decis Making. 2024 Jul;44(5):512-528. doi: 10.1177/0272989X241255047. Epub 2024 Jun 3.
4
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial.巴瑞替尼单抗单药治疗或与etesevimab或sotrovimab联合治疗对轻至中度新冠肺炎患者持续高病毒载量的影响：一项随机2期BLAZE-4试验。
Infect Dis Ther. 2024 Feb;13(2):401-411. doi: 10.1007/s40121-024-00918-1. Epub 2024 Jan 30.
5
Severe COVID-19: Drugs and Clinical Trials.重症新型冠状病毒肺炎：药物与临床试验
J Clin Med. 2023 Apr 16;12(8):2893. doi: 10.3390/jcm12082893.
6
COVID-19 in early 2023: Structure, replication mechanism, variants of SARS-CoV-2, diagnostic tests, and vaccine & drug development studies.2023年初的新型冠状病毒肺炎：严重急性呼吸综合征冠状病毒2的结构、复制机制、变体、诊断测试以及疫苗与药物研发研究
MedComm (2020). 2023 Apr 8;4(2):e228. doi: 10.1002/mco2.228. eCollection 2023 Apr.
7
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.不断演变的 COVID-19 治疗用单克隆抗体的真实世界疗效：一项队列研究。
Ann Intern Med. 2023 Apr;176(4):496-504. doi: 10.7326/M22-1286. Epub 2023 Apr 4.
8
COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center.在一家联邦合格健康中心，COVID-19 单克隆抗体治疗对高危患者症状和新冠后状况的影响。
BMC Infect Dis. 2023 Feb 22;23(1):105. doi: 10.1186/s12879-023-08057-7.
9
Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western India.霉酚酸酯在新型冠状病毒肺炎中的安全性和有效性：印度西部的一项非随机前瞻性研究
Lancet Reg Health Southeast Asia. 2023 Apr;11:100154. doi: 10.1016/j.lansea.2023.100154. Epub 2023 Jan 25.
10
Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis.COVID-19 患者出院后血栓栓塞事件：预防必要性的综述。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296221148477. doi: 10.1177/10760296221148477.